Seline Miller's most recent trade in Catalyst Biosciences Inc was a trade of 3,250 Common Stock done at an average price of $0.5 . Disclosure was reported to the exchange on Aug. 9, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Catalyst Biosciences Inc | Seline Miller | SVP Finance; Interim CFO & PAO | Purchase of securities on an exchange or from another person at price $ 0.47 per share. | 09 Aug 2022 | 3,250 | 6,500 (0%) | 0% | 0.5 | 1,528 | Common Stock |
Catalyst Biosciences Inc | Seline Miller | SVP Finance; Interim CFO & PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 107,500 | 107,500 | - | - | Stock Option (Right to Buy) | |
Catalyst Biosciences Inc | Seline Miller | SVP Finance; Interim CFO & PAO | Purchase of securities on an exchange or from another person at price $ 0.46 per share. | 09 Feb 2022 | 3,250 | 3,250 (0%) | 0% | 0.5 | 1,495 | Common Stock |